Annikki
Senior Member
- Messages
- 146
Hi, I'm new here and while I have another autoimmune disease, I'm startled by the parallels all these diseases have. Anyhow, my disease is called interstitial cystitis. It is an autoimmune condition specific to the bladder in human beings and felines. Don't think for 10 minutes that this disease is any less relenting than ME/CFS; unfortunately doctors think we are crackpots too and won't treat us. Wessely made his comments about us too and they are sticking. Me, I've lost everything just like you dear people can and do thanks to the medical bigotry which won't go away.
Interstitial cystitis or IC is like having a permanent urinary tract infection with no pathogen. You go to the bathroom well over 60 times a day. Your symptoms don't stop at night and sleep becomes impossible as a result. The pain is severe. We too give up, we too must fight for answers to why this happens. Our disease manifests many symptoms which are co-morbid to CFS- we too have shrunken adrenal glands (cats with IC have this too and there are studies about this- Google Tony Buffington for these), mitral valve prolapse, low blood volume. I have symptoms myself which match CFS but to a lesser degree. Yet my bladder renders life impossible for me because this disease is an autoimmune condition where the bladder lining is attacked as opposed to neurons. There are neurons in the bladder, FYI and IC is classified as neurological. I believe it fully is.
Now to the research discussion. I have been spending some time trying to write an article suggesting why testing IC patients for XMRV would be a good idea. Even without studying too hard there are obvious reasons to test it for XMRV. FMS, CFS/ME. Sjogrens, Lupus and more are co-morbid with IC. Strangely so is prostatitis . I say "strangely" because very few men get IC in the first place. Prostatitis is linked to the onset of prostate cancer- I read somewhere that XMRV causes inflammation in the prostate which sets the stage for cancer. Enough with simple, flimsy arguments.
I am aware the XMRV studies are being attacked somewhat relentlessly. Most of my research is using the premise it is XMRV causing IC, CFS, FMS and more. I hope XMRV is still a possible cause. Regardless, in an effort to pin down how XMRV could begin to cause the cascade of IC symptoms I am finding information which secures this autoimmune disease as having the same nature as other autoimmune disease.
What I've found in studying about bladder physiology in relation to IC and other conditions is the same issues- purinergic receptors, nerve cells and ATP abnormalities form the basis of IC symptoms. While surely this sounds very odd to a newbie to the topic, this is all very true. In the bladders of people with interstitial cystitis, there is an abnormally high amount of extracellular ATP. Most researchers are figuring that ATP has a signalling role, and this is very true in the bladder. Stretching a bladder cell can cause it to release ATP- other cells in the body release ATP due to physical changes. All human bladders release ATP during stretch- it is part of the way the nervous system detects if the bladder is full. In IC patients, this level of ATP is very high and studies have ruled out the other things like inability to re-uptake ATP.
I know very well that CFS/ME symptoms have a link to ATP too, and Dr. Light is doing some great work tying purinergic receptors which bind to ATP in CFS and FMS. His work is spot on in my opinion- that is because the pathology of IC is rooted in purinergic receptors too. This is where it gets ugly because I have far too many studies to list, but I'll give it a go.
My original idea is that XMRV in some way is modifying both purinergic receptors and ATP-binding cassettes. One list showed there are XMRV homologues to a few ATP-binding cassettes. I haven't linked the purinergic part to this yet. I'm going to have to read more about mitochondria and how ATP is produced and get a bigger picture of the entire ATP process in healthy people and us.
The interesting part of what I am sharing is that there have been a few new developments in IC research, one of which being a unique siaglogly copeptide found in IC patients urine. Right now my head is spinning over this because p53, a key cancer related gene has been found as the source of this unique siaglogly copeptide in IC officially named "antiproliferative factor (APF)."
It is findings like this which really make it hard for me to shelve XMRV (and I know full well this is a political issue so I'm not buying everything I hear).
Unfortunately, given the sheer enormity of information I'm sifting through right now, I'm going to have to share just dry data and a very brief theory statement. I'm learning about 3 different diseases in tandem, I am having to learn biochemistry as I go, and there are so many good articles out there. The good news is that all the information I'm finding fits together very, very well. I can't help but think we are all working to solve a collective mystery about a disease with different manifestations and is a politically hot item for some damned reason.
For starters, I'm going to share a good article about IC with good basic information and the least amount of Wessely school drivel inserted (yes, the disease is real!!): http://findarticles.com/p/articles/mi_m0FDN/is_4_8/ai_111303984/
Here is my old, fairly simple thesis:
Interstitial cystitis or IC is like having a permanent urinary tract infection with no pathogen. You go to the bathroom well over 60 times a day. Your symptoms don't stop at night and sleep becomes impossible as a result. The pain is severe. We too give up, we too must fight for answers to why this happens. Our disease manifests many symptoms which are co-morbid to CFS- we too have shrunken adrenal glands (cats with IC have this too and there are studies about this- Google Tony Buffington for these), mitral valve prolapse, low blood volume. I have symptoms myself which match CFS but to a lesser degree. Yet my bladder renders life impossible for me because this disease is an autoimmune condition where the bladder lining is attacked as opposed to neurons. There are neurons in the bladder, FYI and IC is classified as neurological. I believe it fully is.
Now to the research discussion. I have been spending some time trying to write an article suggesting why testing IC patients for XMRV would be a good idea. Even without studying too hard there are obvious reasons to test it for XMRV. FMS, CFS/ME. Sjogrens, Lupus and more are co-morbid with IC. Strangely so is prostatitis . I say "strangely" because very few men get IC in the first place. Prostatitis is linked to the onset of prostate cancer- I read somewhere that XMRV causes inflammation in the prostate which sets the stage for cancer. Enough with simple, flimsy arguments.
I am aware the XMRV studies are being attacked somewhat relentlessly. Most of my research is using the premise it is XMRV causing IC, CFS, FMS and more. I hope XMRV is still a possible cause. Regardless, in an effort to pin down how XMRV could begin to cause the cascade of IC symptoms I am finding information which secures this autoimmune disease as having the same nature as other autoimmune disease.
What I've found in studying about bladder physiology in relation to IC and other conditions is the same issues- purinergic receptors, nerve cells and ATP abnormalities form the basis of IC symptoms. While surely this sounds very odd to a newbie to the topic, this is all very true. In the bladders of people with interstitial cystitis, there is an abnormally high amount of extracellular ATP. Most researchers are figuring that ATP has a signalling role, and this is very true in the bladder. Stretching a bladder cell can cause it to release ATP- other cells in the body release ATP due to physical changes. All human bladders release ATP during stretch- it is part of the way the nervous system detects if the bladder is full. In IC patients, this level of ATP is very high and studies have ruled out the other things like inability to re-uptake ATP.
I know very well that CFS/ME symptoms have a link to ATP too, and Dr. Light is doing some great work tying purinergic receptors which bind to ATP in CFS and FMS. His work is spot on in my opinion- that is because the pathology of IC is rooted in purinergic receptors too. This is where it gets ugly because I have far too many studies to list, but I'll give it a go.
My original idea is that XMRV in some way is modifying both purinergic receptors and ATP-binding cassettes. One list showed there are XMRV homologues to a few ATP-binding cassettes. I haven't linked the purinergic part to this yet. I'm going to have to read more about mitochondria and how ATP is produced and get a bigger picture of the entire ATP process in healthy people and us.
The interesting part of what I am sharing is that there have been a few new developments in IC research, one of which being a unique siaglogly copeptide found in IC patients urine. Right now my head is spinning over this because p53, a key cancer related gene has been found as the source of this unique siaglogly copeptide in IC officially named "antiproliferative factor (APF)."
It is findings like this which really make it hard for me to shelve XMRV (and I know full well this is a political issue so I'm not buying everything I hear).
Unfortunately, given the sheer enormity of information I'm sifting through right now, I'm going to have to share just dry data and a very brief theory statement. I'm learning about 3 different diseases in tandem, I am having to learn biochemistry as I go, and there are so many good articles out there. The good news is that all the information I'm finding fits together very, very well. I can't help but think we are all working to solve a collective mystery about a disease with different manifestations and is a politically hot item for some damned reason.
For starters, I'm going to share a good article about IC with good basic information and the least amount of Wessely school drivel inserted (yes, the disease is real!!): http://findarticles.com/p/articles/mi_m0FDN/is_4_8/ai_111303984/
Here is my old, fairly simple thesis:
Notes on IC and ATP
Studies have shown that when bladder epithelial cells are stretched they release ATP. In the bladders of people with interstitial cystitis, more extracellular ATP is released than in control patients.
Quote: (BMJ August 8th, 2009: 339:337-342)
(IC bladder uroepithelial cells released significantly higher concentrations of ATP (adenosine triphosphate) than control biopsies suggesting that ATP plays an important role in this syndrome. An investigation of cultured bladder epithelial cells showed that such cells have an abnormal, much higher concentration of ATP. This higher concentration of ATP decreases the ability of the bladder wall to conduct (channel) potassium ions which again indicates impaired potassium ion conduction is part of the pathology of interstitial cystitis.
Studies on ME/CFS have shown deficient ion channelopathy to be part of the pathology of ME/CFS. Some studies about ME/CFS and potassium conduction attribute this flaw to abnormal mitochondrial gene expression.
The BMJ article cited says studies on IC showing ATP increase and changes in potassium conduction as also resulting from abnormal gene expression.
I suggest the issue of ATP, potassium ion channelopathy as being the result of XMRV. Idiosyncratic production of ATP and its components such as purinergic receptors, ATP- binding cassettes (ABCs) and or ABC transporters is well documented in many other autoimmune diseases and can be fully attributed to the source of most IC symptoms.
I hypothesize these abnormalities are the result the presence of XMRV in interstitial cystitis, and occur through many different mechanisms, including viral mimicry and others.
The hypothesis that XMRV likely cause of significantly high release of ATP in bladder urothelial cells is supported by observed defects in ATP-binding cassette transporters, where XMRV viral mimicry of proteins is likely to have occurred..
About ATP Binding Cassettes
ATP-binding cassette transporters are members of a protein superfamily that is one of the largest and oldest proteins.
ABC transporters are transmembrane proteins that utilize the energy of adenosine triphosphate (ATP) hydrolysis to carry out certain biological processes including the translocation of various substrates across membranes and non-transport related processes such as translation of RNA and DNA repair. ABCs transport a wide variety of substrates across extra and intracellular membranes, including metabolic products, lipids and sterols, and drugs. Proteins are classified as ABC transporters based on the sequence and organization of their ATP-binding cassette (ABC) domain(s). ABC transporters are involved in tumor resistance, cystic fibrosis, bacterial multi drug resistance and a range of other inherited human diseases.
One of these diseases is Pseudoxanthoma Elasticum (PXE), a hereditary connective tissue disease in which proteoglycans have altered properties. In pseudoxanthoma elasticum there are abnormalities which show some relevance to interstitial cystitis. Both diseases show a relationship with sulfated glycosaminoglycans. The only difference is that in PXE, an inherited genetic defect in an ATP-binding cassette transporter identified as ABCC6/MRP6
The idea that ABCC6/MRP6 is the cause of PXE was tested in 2003 in Italy.
Proteoglycan metabolism in PXE was studied by Francesca Maccari, Dealba Gheduzzi and Nicola Vopi at the University of Modena, in Modena, Italy.
In this study, the researchers measured sulfated glycosaminoglycans in the urine of people with PXE, people carrying the disease and healthy controls. Sulfated glycosaminoglycans are what compose the mucosal lining of the human bladder, known as the GAG layer. The GAG layer is deficient in IC patients because the bladder epithelial cells which secrete GAG become compromised and cease to serve their function.
The glycosaminoglycans this study on PXE tested for were chondriotin sulfate disaccharide and heparan sulfate disaccharide. Note also that to treat interstitial cystitis, heparin sulfate is instilled into the bladder to augment the defective GAG layer. In Canada and elsewhere outside the U.S., chondriotin sulfate has been used with even better results than heparin sulfate as a bladder instillation, to help IC patients in those places.
In PXE 34% less of the polysaccharides were detected in the urine of PXE individuals, than controls or unaffected carriers of the genetic defect.
It is worth noting that the commonality between IC and PXE patients may extend beyond glycosaminoglycans being abnormally low. On the revealing of the genome for XMRV, a comparison of what human proteins the XMRV retrovirus mimics finds a link between the virus and ABC transporters.
A retrovirus is different from normal viruses. Normal viruses only have their DNA transcribed into RNA in the host, and the RNA is then translated into a protein. A retrovirus functions in a different way, which more adeptly inserts its genome into human DNA. Retroviruses have their RNA reverse-transcribed into DNA, which is then integrated into the hosts genome and then undergoes the usual transcription and translation processes to express the genes carried by the virus.
How this relates to the issue of XMRV and autoimmune diseases, its speculated that XMRV creates proteins which mimic those in the human body. The idea is that the fake DNA created by the virus initiates a response from the human immune system. Some believe that the human immune system becomes confused from the retroviral proteins which mimic its own proteins. This leads to the unending attack from the body on its own tissue.
There is an ATP-binding cassette associated with the viral mimicry of XMRV infection. It is called ABCC9:
It is known as EAW96452.1. This is an ATP-binding cassette of the subfamily C (CFTR/MRP), member 9, isoform ABCC9. XMRV GAG- PRO-POL was found to mimic the natural properties of this ABC.
Note that ABCC6 in PXE where altered levels of glycosaminoglycans is very closely related to ABCC9. Both of these ATP-binding cassettes are of the subfamily MRP.
However, a link between this possibly compromised ATP binding cassette know as ABCC9 and interstitial cystitis goes further than its proximity in nature to ABCC6.
Here is what the genome mapping project says about ABCC9
ABC proteins transport various molecules across extra and intra cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP sensitive potassium channels in cardiac, skeletal and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel modulating subunit of the extra pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated in cardiomyopathy dilated type 10. Alternative splicing results in multiple transcript variants.
Now we go back to the idea the BMJ article expressed; the idea that come IC pain comes from inability for the bladder epithelial cells in IC patients to channel potassium ions. Also issues involving dysfunctional bladder smooth muscle activity parallel a possible defect in ABCC9 as a causative agent in IC symptoms. Bladder spasms and pelvic floor muscle issues become clearer when the idea of viral mimicry of ABCC9, or other ABCs.
Potassium channeling function by ABCC9 also alludes to the co-morbidity of mitral valve prolapse in interstitial cystitis patients. This too is another trait common to both IC and CFS/ME. Furthermore, defective cassette binders have been linked to the lack of energy proliferation in the bodies of CFS patients. Potassium channeling has also been linked to the pain of fibromyalgia.
The studies of Dr. Light bind the idea that a defect in receptors in the muscle fiber of fibromyalgia patientsreceptors which detect levels of ATP used or not used by the body which is part of the role which ABCs and or ATP sensors like purinergic receptors play in the pathology of that disease.
This makes good enough sense to me. Looking at the many studies which show the prevalence of extracellular ATP in both human and feline IC patients, and furthermore, studies which demonstrate a clear link between extracellular ATP and pain in the human bladders support the idea of ATP being at the root of IC abnormalities.
Source: Augmented Extracellular ATP Signaling in Bladder Urothelial Cells from Patients with Interstitial Cystitis Study by Yan Sun and Toby C. Chai, Division of Urology, Department of Surgery, University of Maryland School of Medicine.
http://apjcell.physiology.org/content/290/1/C27.full
Studies regarding extracellular ATP causing pain in human bladders extend beyond IC research. There was a study performed in Sweden demonstrating that extracellular ATP and the purinergic receptors P2Y are responsible for the inflammatory response in human bladders exposed to the E coli bacteria. Or to put in simple terms, ATP and purinergic receptors which bind to ATP are responsible for the pain and inflammation in the common urinary tract infection.
Bladder stretching itself also causes the bladder epithelial cells to excrete ATP. Studies have ranged from hypothesizing that extracellular ATP serves a role as a signaling mechanism in the human body, where its release upon stretching the human bladder generates the feeling and urge to go. I blame the inability of ABC transporters to serve their role in transporting substrates through intra and extracellular membranes as being part of why some substances irritate IC bladders and cause no sensation of pain in people with normal bladder tissue.
I attribute the experience of interstitial cystitis as being largely dependent upon defective ATP-binding cassette behavior.
I suggest exercise works as an IC therapy because it uses up the extracellular ATP.
I will show proof for my argument in referring to a study which show that extracellular ATP is responsible for other IC anomalies, including the defect where tryptophan in IC patients is broken down into kynurenine over serotonin and melatonin.
The indoleamine 2,3, dioxygenase pathway is the formal name for the modification of tryptophan into various other chemicals.
Here is a study proving that extracellular ATP effects the maturation of human dendritic cells (immune cells), affecting the indoleamine pathway:
Source: Thrombospondin and indoleamine 2,3 dioxygenase are major targets of extracellular ATP in human dendritic cells. Frdrick Marteu, Nathalie Suarez Gonzalez, David Communi, Michel Goldman, Jean-Marie Boeynaems, and Didler Communi. http://bloodjournal.hematologylibrary.org/content/10612/3860.full
This article states:
Extracellular adenosine triphosphate affects the maturation of human dendritic cells, mainly by inhibiting T-helper (Th 1) cytokines, promoting Th2 cytokines and modulating the expression of costimulatory molecules. In this study we report that adenosine triphosphate can induce immunosuppression through its own action on DCs, defining a new role for extracellular nucleotides. Microarray analysis of ATP-stimulated human DCs revealed an inter alia a drastic up-regulation of 2 genes encoding mediators involved in immunosuppression: thrombospondin-1 and indoleamine.."
It is known that bladder stretching causes cells to release ATP. This is one way physical changes alone can alter bladder surface biochemistry.
Furthermore, the amounts of extracellular ATP becomes more prevalent upon mechanical stretch can be reduced by chemicals already present in the bladder. In a study by Sun Y and Chai TC at the Division of Urology at the University of Maryland School of Medicine, both heparin sulfate and dimethyl sulphoxide (DMSO) reduce the higher levels of stretch activated ATP release in the bladders of people with interstitial cystitis.
The idea supported by the results of this study is that bladder epithelial cells (bladder urothelial cells or BUCs) are able to detect levels of ATP and rely upon ATP as a chemical messenger of sorts.
Another thing which stresses the importance of studying the role of ATP in interstitial cystitis is that ATP plays a major role in generating the disease symptoms in other autoimmune disorders:
So you ME/CFS people don't feel left out of this research, know that this is oh, so relevant to solving your problem too. Again, I'm finding good material:
Purinergic Irregularities and Autoimmune Disease
Source: Review: Potential Retrovirus Causal Paths in CFS and FM Rev 2. Laurence G. Felker, Reno, NV (775) 852-9326.
Disregulated immune, endocrine and neurological systems are well known. Adenosine triphosphate (ATP) processing has been clearly shown to be abnormally regulated in CFS and a test is now available which correlates severity of the condition with ATP processing. Evidence also exists which shows other abnormalities in purine regulation contribute to this condition. If extracellular ATP, adenosine diphosphate (ADP) and adenosine monophosphate (AMP) are elevated while adenosine (ADO) is deficient, then multiple effects will occur. Nociceptive input via the P2X3 receptors is elevated. Endocrine disruption can occur. Cellular energy levels are lower accounting for fatigue. Since ADO promotes sleep, its lower levels may account for the sleep disturbances found in CFS.
Here are some of my notes:ATP Cassette Binders, Purinergic Receptors; Role in pathogenesis of Autoimmune and Relation to XMRV Infection
ABC cassettes are related to XMRV infection
ABCE1 ATP-binding cassette, subfamily E (OABP), member 1, [Homo sapiens]
Also known as RNASEL1; RNASELI, RLI, OABP, ABC38
The protein encoded by this gene is a member of the subfamily of ATP binding cassette transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This protein is a member of the OABP subfamily. Alternatively referred to as the RNase L inhibitor, this protein functions to block the activity of ribonuclease L. Activation of ribonuclease L leads to inhibition of protein synthesis in the 2-5A/RNasel L system, the central pathway for viral interferon action. Two transcript variants encoding for the same protein have been found for this gene.
Genomic context:
Chromosome: 4; Location 4q31
ABCC9 ATP-binding cassette, subfamily, C (CFTR/MRP), member 9 [homo sapiens]
Also known as SUR2, ABC 37, CMD1O; FLJ36852
Te protein encoded by this gene is a member of the superfamily of ATP-binding cassette transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinctive subcategories (ABC1, MDR/TAP, ALD, OABP, GCN20, and White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance.
This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants.
Genomic Context:
Chromosome 12; Location 12p12.1
ABCC6/MRP6 transporter
In Pseudoxanthoma Elasticum (PXE) ABCC6 has been found to alter the properties of sulfated glycosaminoglycans.
Researchers believe the presence of altered GAGS in PXE results from an inherited genetic defect in the ABC transporter called ABCC6/MRP6. PXE is a hereditary connective tissue in which proteoglycans have altered properties. PXE is a disease which shares commonalities to interstitial cystitis because in PXE chemical alterations to the sulfated glycosaminoglycans heparan sulfate and chondriotin sulfate occur. In one study the sulfated glycosaminoglycans in the urine of PXE
ABCB1 or MDR1 P-glycoprotein
ABCB1 is involved in other biological processes for which lipid transport is the main function. It is found to mediate the secretion of the steroid aldosterone by the adrenals and its inhibition blocked the migration of dendritic immune cells, possibly related to the outward transport of the lipid platelet activating factor (PAF). It has also been reported that ABCB1 mediates the transport of cortisol and dexametasone, but not of progesterone in ABCB1 transected cells. MDR1 can also transport cholesterol, short-chain and long chain analogues of phosphatidycholaine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), sphinogomyelin (SM), and glucoasylerimide (Glc)Cer.
The human ABCB (MDR/TAP family) is responsible for multi-drug-resistance, (MDR) against a variety of structurally unrelated drugs.
The problem of autoimmune disease patients of having an abnormally high resistance to medications may possibly be explained by abnormalities in ABCB1.
This is a eukaryotic ABC protein. Although most eukaryotic ABC transporters are effluxers, some are not directly involved in transporting substrates. In the cystic fibrosis transmembrane regulator (CFTR) and in the sulfonylurea receptor, ATP hydrolysis is associated with the regulation of opening and closing of ion channels carried by the ABC protein itself or other proteins.
Human ABC transporters are involved in several diseases that arise from polymorphisms in ABC genes and rarely due to complete loss of function by ABC proteins. Such diseases include Mendealian diseases and complex genetic disorders such as cystic fibrosis, adrenoleukodaystrophy, Pseudoxanthoma elasticum, and more.
(Source: Wikipedia, ABC transporters article)
XMRV Viral homologues to human
Proteins.
ABCC9/ EAW96452.1 ATP binding cassette, sub family C (CFTR/MRP, member 9, isoform.
This protein is thought to form ATP sensitive potassium channels in cardiac, skeletal and vascular and non-vascular smooth muscle.
Homologous proteins
[LE* D*IFP*RF MP*+]
ATP2C1 EAW79217.1 ATPase, Ca+ transporting, type 2C, member 1, isoform CRA_a[Homo
This magnesium dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium, XMRV ENV.
Here now are some studies and articles which lay out how there is something very unique going on with ATP and what it binds to in interstitial cystitis. One very interesting tidbit worth knowing is that abnormal breakdown of tryptophan to kynurenine; a process that happens in my disease, yours and fibromyalgia has been linked to extracellular ATP and its affects on dendrite development. Yes, I'm not going to be wasting your time- I'm sharing information which seems to be getting so fruitful, I am struggling to get through all of it.
Oh, BTW, here's that article about Antiproliferative Factor, p53 and IC: "P53 regulates two ATP-generating pathways; p53 is gene responsible for Antiproliferative Factor (APF) in interstitial cystitis
Differential Utilization of two ATP-regulating pathways is regulated by p53
by Wissam Assaily and Samuel Benchimol, Department of Biology, York University, Toronto, Ontario, Canada.
http://www.sciencedirect.com/science/article/pii/S15356108060019166